Investigation of risk factors for invasive pulmonary aspergillosis among patients with COVID-19.

Sci Rep

Department of Infectious Diseases, Qilu Hospital of Shandong University, Wenhua Xi Road 107, Jinan, 250012, Shandong, China.

Published: September 2024

AI Article Synopsis

  • COVID-19 associated pulmonary aspergillosis (CAPA) poses high mortality risks, prompting a study to identify its risk factors among 114 COVID-19 patients.
  • The study compared demographics, underlying conditions, lab results, and treatment plans between patients who developed CAPA and those who did not.
  • Key independent risk factors for CAPA found were elevated IL-6 levels, decreased CD4+ T cells, and prolonged mechanical ventilation, highlighting the need for early antifungal treatment to improve patient outcomes.

Article Abstract

COVID-19 associated pulmonary aspergillosis (CAPA) had been reported, and raised concern about this secondary infection due to the high mortality. This study aimed to investigate the risk factors for CAPA. The enrolled 114 COVID-19 patients were further divided into CAPA group and non-CAPA group. Demographic characteristics, underlying diseases, laboratory parameters and therapeutic schedule between the two groups were compared to identify the independent risk factors for CAPA by univariate analysis and multivariable logistic regression analysis. Sensitivity and specificity of independent risk factors were confirmed by receiver operating characteristic (ROC) curve analysis. Univariate analysis showed that renal transplant, IL-6 and CRP levels, decreased CD4 + T cell and CD8 + T cell, duration of antibiotics therapy, and prolonged mechanical ventilation were risk factors for development of CAPA. These factors were further analyzed by multivariable logistic regression analysis and the results indicated that elevated IL-6 level, decreased CD4 + T cell and prolonged mechanical ventilation could be recognized as independent risk factors for CAPA in COVID-19 patients. Identification of these risk factors is essential to initiate antifungal therapy as soon as possible to improve outcome of patients with CAPA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11369242PMC
http://dx.doi.org/10.1038/s41598-024-71455-7DOI Listing

Publication Analysis

Top Keywords

risk factors
28
factors capa
12
independent risk
12
factors
8
pulmonary aspergillosis
8
covid-19 patients
8
univariate analysis
8
multivariable logistic
8
logistic regression
8
regression analysis
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!